48 related articles for article (PubMed ID: 27618362)
1. Clinical implication by differential analytical performances of serum free light chain quantitation analysis using fully automated analyzers.
Yun SY; Rim JH; Park H; Kang H; Lee SG; Lim JB
Clin Chem Lab Med; 2023 Jun; 61(7):1288-1299. PubMed ID: 37015073
[TBL] [Abstract][Full Text] [Related]
2. Clinical specificity of two assays for immunoglobulin kappa and lambda free light chains.
Farnsworth CW; Roemmich B; Spears GM; Murray DL; Dispenzieri A; Willrich MAV
Clin Chem Lab Med; 2024 Apr; 62(5):929-938. PubMed ID: 38044587
[TBL] [Abstract][Full Text] [Related]
3. Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance.
Rajkumar SV; Kyle RA; Therneau TM; Melton LJ; Bradwell AR; Clark RJ; Larson DR; Plevak MF; Dispenzieri A; Katzmann JA
Blood; 2005 Aug; 106(3):812-7. PubMed ID: 15855274
[TBL] [Abstract][Full Text] [Related]
4. Differences in kappa to lambda (kappa:lambda) ratios of serum and urinary free light chains.
Abe M; Goto T; Kosaka M; Wolfenbarger D; Weiss DT; Solomon A
Clin Exp Immunol; 1998 Feb; 111(2):457-62. PubMed ID: 9486419
[TBL] [Abstract][Full Text] [Related]
5. Kappa Free Light Chain Drift Prompts the Need for a New Upper Limit of Normal Free Light Chain Ratio to Avoid an Epidemic of Kappa Light Chain Monoclonal Gammopathy of Undermined Significance.
Rozenova K; Willrich M; Snyder M; Dasari S; Kourelis T; Rajkumar SV; Kumar S; Dispenzieri A; Murray DL
J Appl Lab Med; 2023 Jul; 8(4):742-750. PubMed ID: 37232112
[TBL] [Abstract][Full Text] [Related]
6. Alteration of the Gut Microbiome in Chronic Kidney Disease Patients and Its Association With Serum Free Immunoglobulin Light Chains.
Liu F; Xu X; Chao L; Chen K; Shao A; Sun D; Hong Y; Hu R; Jiang P; Zhang N; Xiao Y; Yan F; Feng N
Front Immunol; 2021; 12():609700. PubMed ID: 33868230
[TBL] [Abstract][Full Text] [Related]
7. The Association between Polyclonal Combined Serum Free Light Chain Concentration and Mortality in Individuals with Early Chronic Kidney Disease.
Assi LK; McIntyre N; Fraser S; Harris S; Hutchison CA; McIntyre CW; Cockwell P; Taal MW
PLoS One; 2015; 10(7):e0129980. PubMed ID: 26132658
[TBL] [Abstract][Full Text] [Related]
8. Association of Serum Free Light Chain Level with Long-Term Kidney Function in Patients with Newly Diagnosed Multiple Myeloma.
Lopedote P; Alhaddad J; Zheng G; Abualshar M; Ghanta S; Kozyreva O; Jaber BL
Nephron; 2024; 148(6):399-407. PubMed ID: 38113858
[TBL] [Abstract][Full Text] [Related]
9. Data analytics improves the diagnostic accuracy of serum free light chain results for detecting monoclonal gammopathy.
Treger RS; Mathias PC; Cowan AJ; Green D; Hutchinson K; Bryan A; Chaudhary A; Fink SL; Wener MH; Morishima C
Am J Clin Pathol; 2024 Mar; 161(3):216-231. PubMed ID: 37936261
[TBL] [Abstract][Full Text] [Related]
10. Method Comparison and Workflow Differences Using the Same Free Light Chain Assay on 2 Analyzer Platforms.
Omosule CL; Hock KG; Dalton C; Scalpati A; Gronowski AM; Brants A; Farnsworth CW
J Appl Lab Med; 2023 Jul; 8(4):689-699. PubMed ID: 37186660
[TBL] [Abstract][Full Text] [Related]
11. Serum free immunoglobulin light chain fingerprint identifies a subset of newly diagnosed multiple myeloma patients with worse outcome.
Avivi I; Cohen YC; Joffe E; Benyamini N; Held-Kuznetsov V; Trestman S; Terpos E; Dimopoulos MA; Kastritis E
Hematol Oncol; 2017 Dec; 35(4):734-740. PubMed ID: 27641057
[TBL] [Abstract][Full Text] [Related]
12. Aberrant p15, p16, p53, and DAPK Gene Methylation in Myelomagenesis: Clinical and Prognostic Implications.
Geraldes C; Gonçalves AC; Cortesão E; Pereira MI; Roque A; Paiva A; Ribeiro L; Nascimento-Costa JM; Sarmento-Ribeiro AB
Clin Lymphoma Myeloma Leuk; 2016 Dec; 16(12):713-720.e2. PubMed ID: 27622827
[TBL] [Abstract][Full Text] [Related]
13. Using Two Detection Methods to Observe the Changes and Significance of Free Light Chain in Serum and Urine in Patients with Renal Insufficiency.
Xu L; Zhao B; Sun Y; Wang S; Chen X; Mao Y
Biomed Res Int; 2022; 2022():5536199. PubMed ID: 35392256
[TBL] [Abstract][Full Text] [Related]
14. Baseline and Changes in Serum B-Cell Maturation Antigen Levels Rapidly Indicate Changes in Clinical Status Among Patients with Relapsed/Refractory Multiple Myeloma Starting New Therapy.
Bujarski S; Udd K; Soof C; Chen H; Spektor TM; Safaie T; Li M; Stern J; Wang C; Xu N; Emamy-Sadr M; Swift R; Rahbari A; Patil S; Souther E; Regidor B; Sutanto C; Berenson JR
Target Oncol; 2021 Jul; 16(4):503-515. PubMed ID: 34097243
[TBL] [Abstract][Full Text] [Related]
15. How to quantify monoclonal free light chains in plasma cell disorders: which mass spectrometry technology?
Moreau C; Lefevre CR; Decaux O
Ann Transl Med; 2020 Aug; 8(15):973. PubMed ID: 32953773
[No Abstract] [Full Text] [Related]
16. Comparison of 2 Serum-Free Light-Chain Assays in CKD Patients.
Sprangers B; Claes K; Evenepoel P; Kuypers D; Poesen K; Delforge M; Bossuyt V X; Meijers B
Kidney Int Rep; 2020 May; 5(5):627-631. PubMed ID: 32405584
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the Impact of Renal Failure on Correlation and Concordance Between 2 Free Light Chain Assays.
Moreau C; Autier B; Cavey T; Rouger E; Norwood J; Bendavid C; Escoffre M; Sébillot M; Decaux O
Clin Lymphoma Myeloma Leuk; 2016 Dec; 16(12):693-704. PubMed ID: 27618362
[TBL] [Abstract][Full Text] [Related]
18. Serum Free Light Chain Assay: Shift Toward a Higher κ/λ Ratio.
Rindlisbacher B; Schild C; Egger F; Bacher VU; Pabst T; Leichtle A; Andres M; Sédille-Mostafaie N
J Appl Lab Med; 2020 Jan; 5(1):114-125. PubMed ID: 32445339
[TBL] [Abstract][Full Text] [Related]
19. Effects of Long-Term Storage on Serum Free Light Chain Stability.
Hörber S; Klein R; Peter A
Clin Lab; 2019 May; 65(5):. PubMed ID: 31115238
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
